Home > Insider Trading > Filing (0001477932-21-004848)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1187953	Creative Medical Technology Holdings Inc.	CELZ	Biological Products, (No Disgnostic Substances) (2836)	870622284

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1429928	Thomas Ichim	211 E. Osborn Rd Phoenix AZ 85012		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-07-20	1,400,000	$0.03	7,479,522	No	4	S	Direct
Common Stock	Disposition	2021-07-21	1,500,000	$0.03	5,979,522	No	4	S	Direct
Common Stock	Disposition	2021-07-22	1,450,000	$0.03	4,529,522	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	17,245	Indirect	By LLC

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.03 to $0.030521, inclusive. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the foregoing ranges.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.031. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices of $0.03 and $0.0305. The reporting person undertakes to provide to the Issuer and the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price.
Shares are held by BioTech Holdings, LLC, of which the reporting person is President. The reporting person disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein.